La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « Substantia Nigra (drug effects) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Substantia Nigra (diagnostic imaging) < Substantia Nigra (drug effects) < Substantia Nigra (embryology)  Facettes :

List of bibliographic references indexed by Substantia Nigra (drug effects)

Number of relevant bibliographic references: 39.
[0-20] [0 - 20][0 - 39][20-38][20-40]
Ident.Authors (with country if any)Title
000120 (2017) Candace H. Carriere [Canada] ; Na Hyea Kang [Canada] ; Lennard P. Niles [Canada]Bilateral upregulation of α-synuclein expression in the mouse substantia nigra by intracranial rotenone treatment.
000153 (2016) Qing He [République populaire de Chine] ; James B. Koprich [Canada] ; Ying Wang [République populaire de Chine] ; Wen-Bo Yu [République populaire de Chine] ; Bao-Guo Xiao [République populaire de Chine] ; Jonathan M. Brotchie [Canada] ; Jian Wang [République populaire de Chine]Treatment with Trehalose Prevents Behavioral and Neurochemical Deficits Produced in an AAV α-Synuclein Rat Model of Parkinson's Disease.
000623 (2015) Ali H. Rajput [Canada] ; Michele L. Rajput [Canada] ; Christopher A. Robinson [Canada] ; Alex Rajput [Canada]Normal substantia nigra patients treated with levodopa - Clinical, therapeutic and pathological observations.
000987 (2014) Krithika Muthukumaran [Canada] ; Samantha Leahy [Canada] ; Kate Harrison [Canada] ; Marianna Sikorska [Canada] ; Jagdeep K. Sandhu [Canada] ; Jerome Cohen [Canada] ; Corrine Keshan [Canada] ; Daniel Lopatin [Canada] ; Harvey Miller [Canada] ; Henryk Borowy-Borowski [Canada] ; Patricia Lanthier [Canada] ; Shelly Weinstock [États-Unis] ; Siyaram Pandey [Canada]Orally delivered water soluble Coenzyme Q10 (Ubisol-Q10) blocks on-going neurodegeneration in rats exposed to paraquat: potential for therapeutic application in Parkinson’s disease
000C97 (2013) Matthew P. Mount ; Yi Zhang ; Mandana Amini ; Steve Callaghan ; Jerzy Kulczycki ; Zixu Mao ; Ruth S. Slack ; Hymie Anisman ; David S. ParkPerturbation of Transcription Factor Nur77 Expression Mediated by Myocyte Enhancer Factor 2D (MEF2D) Regulates Dopaminergic Neuron Loss in Response to 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)*
000D83 (2013) Maria Gabriela Sánchez [Canada] ; Marc Morissette ; Thérèse Di PaoloEstradiol and brain serotonin reuptake transporter in long-term ovariectomized parkinsonian monkeys.
000E04 (2013) Scott Mackey [États-Unis] ; Yu Jing ; Joseph Flores ; Katie Dinelle ; Doris J. DoudetDirect intranigral administration of an ubiquitin proteasome system inhibitor in rat: behavior, positron emission tomography, immunohistochemistry.
001F18 (2009) I. A. Prescott [Canada] ; J. O. Dostrovsky [Canada] ; E. Moro [Canada] ; M. Hodaie [Canada] ; A. M. Lozano [Canada] ; W. D. Hutchison [Canada]Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients
002429 (2007) Mojgan Hodaie [Canada] ; Joseph S. Neimat ; Andres M. LozanoThe dopaminergic nigrostriatal system and Parkinson's disease: molecular events in development, disease, and cell death, and new therapeutic strategies.
002905 (2006) J. Miklossy [Canada] ; D. D. Doudet [Canada] ; C. Schwab [Canada] ; S. Yu [Canada] ; E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada]Role of ICAM-1 in persisting inflammation in parkinson disease and MPTP monkeys
002A09 (2005) K. Adam Baker [Canada] ; Ivar Mendez [Canada]Long distance selective fiber outgrowth of transplanted hNT neurons in white matter tracts of the adult rat brain
002A20 (2005) Gerlinde A. Metz [Canada] ; Arthur Tse ; Mark Ballermann [Canada] ; Lori K. Smith [Canada] ; Karim Fouad [Canada]The unilateral 6‐OHDA rat model of Parkinson's disease revisited: an electromyographic and behavioural analysis
002B79 (2004) Ronald B. Postuma [Canada] ; Anthony E. LangHomocysteine and levodopa: should Parkinson disease patients receive preventative therapy?
002B93 (2004) Anthony E. Lang [Canada] ; Jose A. ObesoChallenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough.
002D79 (2003) Stephen J. Crocker [Canada] ; Patrice D. Smith ; Vernice Jackson-Lewis ; Wiplore R. Lamba ; Shawn P. Hayley ; Erich Grimm ; Steve M. Callaghan ; Ruth S. Slack ; Edon Melloni ; Serge Przedborski ; George S. Robertson ; Hymie Anisman ; Zul Merali ; David S. ParkInhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease.
002E00 (2003) Patricia Vergara-Aragon ; Claudia L R. Gonzalez ; Ian Q. WhishawA novel skilled-reaching impairment in paw supination on the "good" side of the hemi-Parkinson rat improved with rehabilitation.
003109 (2001) C. Zhang [Canada] ; J P Steiner ; G S Hamilton ; T P Hicks ; M O PoulterRegeneration of dopaminergic function in 6-hydroxydopamine-lesioned rats by neuroimmunophilin ligand treatment.
003210 (2001) Ali H. Rajput [Canada]Levodopa prolongs life expectancy and is non-toxic to substantia nigra
003252 (2001) Gerlinde A. S. Metz ; Tracy Farr ; Mark Ballermann ; Ian Q. WhishawChronic levodopa therapy does not improve skilled reach accuracy or reach range on a pasta matrix reaching task in 6‐OHDA dopamine‐depleted (hemi‐Parkinson analogue) rats
003277 (2001) Ali H. Rajput [Canada]The protective role of levodopa in the human substantia nigra
003440 (2000) Sophie Callier [Canada, France] ; Marc Morissette [Canada] ; Michelle Grbois [Canada] ; Thérèse Di Paolo [Canada]Stereospecific prevention by 17β‐estradiol of MPTP‐induced dopamine depletion in mice

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Substantia Nigra (drug effects)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Substantia Nigra (drug effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Substantia Nigra (drug effects)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022